Aethlon Medical (NASDAQ:AEMD) Announces Quarterly Earnings Results

Aethlon Medical (NASDAQ:AEMD) announced its quarterly earnings data on Wednesday. The medical equipment provider reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.09, Zacks reports.

Aethlon Medical Price Performance

Shares of NASDAQ:AEMD traded down $0.01 during trading on Wednesday, reaching $0.67. The company had a trading volume of 571,242 shares, compared to its average volume of 1,213,222. The firm has a market capitalization of $9.33 million, a price-to-earnings ratio of -0.24 and a beta of 1.88. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $1.85. The stock’s fifty day moving average price is $0.62 and its 200 day moving average price is $0.47.

Analysts Set New Price Targets

Several research analysts have commented on the stock. StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Monday, January 27th. They issued a “sell” rating on the stock. HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a research note on Thursday, January 30th.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.